Website: https://www.pll-therapeutics.com/
Member Contact: Dr Jean Pascal Zambaux
Position: CEO
Industry: Biotech & Pharmaceuticals
Company Profile:
PPL TX Australia a subsidiary of PLL Therapeutics offers a drug delivery platform via polypeptides, an early diagnostic tool and numerous therapeutic targets to stabilize auto immune and neurodegenerative diseases as early as possible.
At first application on Amyotrophic Lateral Sclerosis (ALS) with a clinical Trial Phase I II in Australia.